These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


771 related items for PubMed ID: 28056881

  • 21. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X, Li T, Xu X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [Abstract] [Full Text] [Related]

  • 22. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 23. The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers.
    Arraes LC, Ximenes R, Andrieu JM, Lu W, Barreto S, Pereira LM, Castelo A.
    Rev Inst Med Trop Sao Paulo; 2003 Jan; 45(3):137-40. PubMed ID: 12870062
    [Abstract] [Full Text] [Related]

  • 24. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M, Ali R, Khan LA, Husain SA, Singla R, Kar P.
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
    Romanò L, Velati C, Cambiè G, Fomiatti L, Galli C, Zanetti AR, SIMTI study group for HBV infection among first-time blood donors.
    Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L, Adegoke AO, Aboderin AO, Huraina HA.
    West Afr J Med; 2011 Apr; 30(4):292-5. PubMed ID: 22669836
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.
    Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, Laperche S, Sanogo R, Allain JP, Simpore J.
    J Med Virol; 2016 Dec; 88(12):2145-2156. PubMed ID: 27253483
    [Abstract] [Full Text] [Related]

  • 31. The detection of HBV DNA with polymerase chain reaction in blood donors with isolated hepatitis B core antibody.
    Tas T, Kaya S, Onal S, Kucukbayrak A.
    Med Glas (Zenica); 2012 Aug; 9(2):227-30. PubMed ID: 22926355
    [Abstract] [Full Text] [Related]

  • 32. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers.
    Douglas DD, Taswell HF, Rakela J, Rabe D.
    Transfusion; 1993 Mar; 33(3):212-6. PubMed ID: 8438221
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.
    Alzahrani FM, Muzaheed, Shaikh SS, Alomar AI, Acharya S, Elhadi N.
    Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234
    [Abstract] [Full Text] [Related]

  • 34. Population-based study of serum hepatitis B virus DNA in Gabon.
    Dazza MC, Trebucq A, Gaudebout C, Jarretou A, Le Hesran JY, Josse R, Delaporte E, Bréchot C, Larouze B.
    Trans R Soc Trop Med Hyg; 1993 Jan; 87(5):539-40. PubMed ID: 8266404
    [Abstract] [Full Text] [Related]

  • 35. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
    Zhang L, Liu JY, Lyu JJ, Yan BY, Feng Y, Wu WL, Song LZ, Xu AQ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun 06; 51(6):475-479. PubMed ID: 28592088
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B virus genotype D predominates HBsAg-positive egyptian blood donors and is mainly associated with a negative HBeAg serostatus.
    Habil FE, Mahdi WK, Abdelwahab SF, Abdel-Hamid M.
    Intervirology; 2013 Jun 06; 56(5):278-83. PubMed ID: 23887183
    [Abstract] [Full Text] [Related]

  • 37. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb 06; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 38. [Molecular epidemiology of hepatitis B virus in Northern Cyprus].
    Arıkan A, Şanlıdağ T, Süer K, Sayan M, Akçalı S, Güler E.
    Mikrobiyol Bul; 2016 Jan 06; 50(1):86-93. PubMed ID: 27058332
    [Abstract] [Full Text] [Related]

  • 39. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
    Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML.
    J Infect; 2005 Jul 06; 51(1):24-9. PubMed ID: 15979486
    [Abstract] [Full Text] [Related]

  • 40. Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique.
    Mabunda N, Zicai AF, Ismael N, Vubil A, Mello F, Blackard JT, Lago B, Duarte V, Moraes M, Lewis L, Jani I.
    Mem Inst Oswaldo Cruz; 2020 Jul 06; 115():e200006. PubMed ID: 32997000
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.